V001-BCMA Clinical Trials
2 recruitingDrug
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening
Advanced Malignant Tumours
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT07395479
Recruiting
Early Phase 1
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
Recurrent or Refractory Systemic Lupus ErythematosusRecurrent or Refractory IgG4 Related DiseasesRecurrent or Refractory Systemic Sclerosis+2 more
Tongji Hospital45 enrolled1 locationNCT07339540